Suggested Topics within your search.
Suggested Topics within your search.
Article
1
Breast cancer
1
Fulvestrant
Palbociclib
1
Prognostic factors
1
Serum markers
1
Thymidine kinase
1
adult
1
aged
1
cancer combination chemotherapy
1
cancer patient
1
cancer prognosis
1
clinical feature
1
controlled study
1
drug dose sequence
1
enzyme activity
1
enzyme linked immunosorbent assay
1
female
1
follow up
1
fulvestrant
1
hormone receptor-positive, HER2-negative breast cancer
1
human
1
limit of detection
1
major clinical study
1
metastatic breast cancer
1
multicenter study
1
multiple cycle treatment
1
palbociclib
1
phase 2 clinical trial
1
postmenopause
1
-
1by Ballestrero, A., Benelli, M., Bergqvist, M., Bernardo, A., Bliss, J.M, Bonetti, A., Breast International Group and PYTHIA Collaborators, Cameron, D., Colleoni, M., Davies, D.M, De Swert, H., Duhoux, F.P, Fumagalli, D., Gebhart, G., Henry, S., Hilbers, F.S, Ignatiadis, M., International Breast Cancer Study Group, Jerusalem, G., Kammler, R., Loi, S., MacPherson, I.R, Maibach, R., Malorni, L., McCartney, A., Migliaccio, I., Neven, P., Papadimitriou, K., Piccart, M., Regan, M.M, Ruepp, B., Seles, E., Thomson, A., Tyekucheva, S., Zoppoli, G.View Fulltext in Publisher
Published 2022
Article